Among the set of immunohistochemical markers, GATA3 and KRT5/6 have emerged as an effective surrogate molecular classifier of bladder cancer that correctly identified the molecular subtypes in over 80% of the cases. Here, GATA3 is linked to urinary bladder cancer.